CATHEPSIN-HEMMER

Patent europeic · EP4046987 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4046987
Numer da la dumonda
EP22150956
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-12-2018
Publitgà
24-08-2022
Concedì
27-08-2025
La protecziun finescha il pli tard
04-12-2038
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07C 317/14 (2006.01)
A61K 31/165 (2006.01)
A61P 19/10 (2006.01)
Prioritad
NL 2020021 05.12.2017
NL 2021544 03.09.2018
Derivà da
EP18839759
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-07-2026

    Midada

    Published in Swissreg on 08.07.2026

  2. 06-01-2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 06.01.2026

  3. 16-10-2025

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 16.10.2025

  4. 27-08-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.08.2025

Partidas

Possessur

Academisch Ziekenhuis Leiden h.o.d.n. LUMC

Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)

Albinusdreef 2, 2333 ZA Leiden, NL

Represchentant

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventur

OVAA, Huib

2333 ZA Leiden, NL

MONS, Maria, Wilhelmina, Elisabet

2333 ZA Leiden, NL

VAN BOECKEL, Stan

2333 ZA Leiden, NL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.